Moderna's Nasdaq-100 Inclusion Lifts Biotech Stocks
Moderna's (MRNA) upcoming inclusion in the Nasdaq-100 index has drawn renewed attention to other biotech stocks, specifically Sellas Life Sciences (SLS) and ImmunityBio (IBRX), as investors compare their cancer-treatment prospects.